Johnson & Johnson Stock Forecast, Price & News

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last twelve months. There are currently 2 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Johnson & Johnson stock.
View analyst ratings for Johnson & Johnson or view top-rated stocks.

Wall Street analysts have given Johnson & Johnson a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Johnson & Johnson wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Johnson & Johnson is scheduled to release its next quarterly earnings announcement on Thursday, July 15th 2021.
View our earnings forecast for Johnson & Johnson.

Johnson & Johnson (NYSE:JNJ) released its quarterly earnings results on Monday, April, 19th. The company reported $2.59 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $2.34 by $0.25. The firm had revenue of $22.30 billion for the quarter, compared to the consensus estimate of $22 billion. Johnson & Johnson had a net margin of 21.01% and a trailing twelve-month return on equity of 34.64%. Johnson & Johnson's revenue was up 7.8% compared to the same quarter last year. During the same period last year, the firm earned $2.30 EPS.
View Johnson & Johnson's earnings history.

Johnson & Johnson's stock was trading at $131.80 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, JNJ shares have increased by 28.1% and is now trading at $168.88.
View which stocks have been most impacted by COVID-19.

Johnson & Johnson declared a quarterly dividend on Tuesday, April 20th. Shareholders of record on Tuesday, May 25th will be given a dividend of $1.06 per share on Tuesday, June 8th. This represents a $4.24 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend is Monday, May 24th. This is a boost from Johnson & Johnson's previous quarterly dividend of $1.01.
View Johnson & Johnson's dividend history.

Johnson & Johnson pays an annual dividend of $4.04 per share and currently has a dividend yield of 2.37%. Johnson & Johnson has been increasing its dividend for 59 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Johnson & Johnson is 46.54%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Johnson & Johnson will have a dividend payout ratio of 45.44% next year. This indicates that Johnson & Johnson will be able to sustain or increase its dividend.
View Johnson & Johnson's dividend history.

Johnson & Johnson updated its FY 2021 earnings guidance on Tuesday, May, 4th. The company provided earnings per share (EPS) guidance of 9.420-9.570 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.500. The company issued revenue guidance of $90.60 billion-$91.60 billion, compared to the consensus revenue estimate of $92.23 billion.

12 brokerages have issued 1-year price objectives for Johnson & Johnson's shares. Their forecasts range from $164.00 to $200.00. On average, they expect Johnson & Johnson's stock price to reach $185.70 in the next twelve months. This suggests a possible upside of 10.0% from the stock's current price.
View analysts' price targets for Johnson & Johnson or view top-rated stocks among Wall Street analysts.

2,535 employees have rated Johnson & Johnson CEO Alex Gorsky on Glassdoor.com. Alex Gorsky has an approval rating of 94% among Johnson & Johnson's employees. This puts Alex Gorsky in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Johnson & Johnson include Pfizer (PFE), AbbVie (ABBV), Merck & Co., Inc. (MRK), Eli Lilly and (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics Public (HZNP), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Pacira BioSciences (PCRX), Corcept Therapeutics (CORT), Supernus Pharmaceuticals (SUPN) and Endo International (ENDP).
View all of JNJ's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Pfizer (PFE), Verizon Communications (VZ), The Walt Disney (DIS), NVIDIA (NVDA), Intel (INTC), JPMorgan Chase & Co. (JPM), Cisco Systems (CSCO), The Procter & Gamble (PG) and AbbVie (ABBV).

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."

Johnson & Johnson's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.20%), Robert Wood Johnson Foundation (0.49%), Swiss National Bank (0.42%), Sumitomo Mitsui Trust Holdings Inc. (0.34%), Flossbach Von Storch AG (0.33%) and Sanders Capital LLC (0.32%). Company insiders that own Johnson & Johnson stock include Ashley Mcevoy, Hubert Joly, Kathryn E Wengel, Marillyn A Hewson, Michael E Sneed and William D Perez.
View institutional ownership trends for Johnson & Johnson.

JNJ stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Bank of Nova Scotia, Schafer Cullen Capital Management Inc, Lord Abbett & CO. LLC, Assenagon Asset Management S.A., MUFG Securities EMEA plc, LSV Asset Management, and Retirement Systems of Alabama. Company insiders that have sold Johnson & Johnson company stock in the last year include Ashley Mcevoy, Kathryn E Wengel, and Michael E Sneed.
View insider buying and selling activity for Johnson & Johnson or view top insider-selling stocks.

JNJ stock was purchased by a variety of institutional investors in the last quarter, including Sanders Capital LLC, BlackRock Inc., Cullen Capital Management LLC, GSB Wealth Management LLC, DekaBank Deutsche Girozentrale, Envestnet Asset Management Inc., Capital Wealth Planning LLC, and Bank Julius Baer & Co. Ltd Zurich. Company insiders that have bought Johnson & Johnson stock in the last two years include Hubert Joly, Marillyn A Hewson, and William D Perez.
View insider buying and selling activity for Johnson & Johnson or or view top insider-buying stocks.

Shares of JNJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of JNJ stock can currently be purchased for approximately $168.88.

Johnson & Johnson has a market capitalization of $444.73 billion and generates $82.06 billion in revenue each year. The company earns $15.12 billion in net income (profit) each year or $8.68 on an earnings per share basis.

Johnson & Johnson employs 134,500 workers across the globe.

The following companies are subsidiares of Johnson & Johnson: ALZA Corporation, Abott Medical Optics, Acclarent, Actelion Pharmaceuticals, Advanced Sterilization Products Services Inc., Alios BioPharma, Animas Corporation, Apsis, Apsis Germany GmbH, Aragon Pharmaceuticals, Auris Health, Beijing Dabao Cosmetics Co., Berna Rhein B.V., BioMedical Enterprises, Biosense Webster, Biosense Webster (Israel) Ltd., CNA Development GmbH, Centocor Research & Development, Ci:z Holdings, Cilag AG, Cilag GmbH International, Cilag Holding AG, Cilag Holding Finance Unlimited Company, Cilag Pharmaceuticals GmbH, Codman & Shurtleff, Coherex Medical, Conor MedSystems, Cordis Financing Corporation, Cordis LLC, Cordis de Mexico, Covagen AG, Crucell N.V., DePuy France, DePuy International Limited, DePuy Ireland Unlimited Company, DePuy Mitek, DePuy Orthopaedics, DePuy Products, DePuy Spine, DePuy Synthes, DePuy Synthes Apollo Limited, DePuy Synthes Eos Limited, DePuy Synthes Gorgan Limited, DePuy Synthes Jason Limited, DePuy Synthes Leto S.A.R.L., DePuy Synthes Products, DePuy Synthes Sales, Diabetes Diagnostics, EES, Ethicon, Ethicon Endo-Surgery, Ethicon Endo-Surgery LLC, Ethicon Holding Sarl, Ethicon Ireland, Ethicon LLC, Ethicon PR Holdings, Ethicon US, Ethicon Women's Health & Urology Sarl, Ethnor del Istmo, FMS Future Medical System SA, GMED Healthcare BVBA, Global Investment Participation B.V., J&J Holdings (Nevada), J-C Health Care Ltd., J.C. General Services CVBA, JJC Acquisition Company B.V., JJHC, JNJ International Investment LLC, JOM Pharmaceutical Services, Janssen, Janssen Biologics (Ireland), Janssen Biologics B.V., Janssen Biotech, Janssen Cilag Farmaceutica S.A., Janssen Egypt, Janssen Global Services, Janssen Infectious Diseases-Diagnostics BVBA, Janssen Irish Finance Company UC, Janssen Korea Ltd., Janssen Oncology, Janssen Ortho LLC, Janssen Pharmaceutica NV, Janssen Pharmaceutical, Janssen Pharmaceutical K.K., Janssen Pharmaceutical Sciences Unlimited Company, Janssen Pharmaceuticals, Janssen Products, Janssen R&D Ireland, Janssen Research & Development, Janssen Sciences Ireland UC, Janssen Scientific Affairs, Janssen Supply Group, Janssen Vaccines & Prevention B.V., Janssen Vaccines AG, Janssen Vaccines Corp., Janssen de Mexico, Janssen-Cilag, Janssen-Cilag A/S, Janssen-Cilag AB, Janssen-Cilag AG, Janssen-Cilag AS, Janssen-Cilag B.V., Janssen-Cilag Farmaceutica, Janssen-Cilag Farmaceutica Ltda., Janssen-Cilag GmbH, Janssen-Cilag Kft., Janssen-Cilag Limited, Janssen-Cilag Limited (UK), Janssen-Cilag Manufacturing, Janssen-Cilag NV, Janssen-Cilag OY, Janssen-Cilag Pharma GmbH, Janssen-Cilag Pharmaceutical S.A.C.I., Janssen-Cilag Pty Ltd, Janssen-Cilag S.A., Janssen-Cilag S.A., Janssen-Cilag S.A. de C.V., Janssen-Cilag S.p.A., Janssen-Cilag de Mexico, Johnson & Johnson (China) Investment Ltd., Johnson & Johnson (China) Ltd., Johnson & Johnson (Hong Kong) Limited, Johnson & Johnson (Ireland) Limited, Johnson & Johnson (Middle East) Inc., Johnson & Johnson (New Zealand) Limited, Johnson & Johnson (Philippines), Johnson & Johnson (Proprietary) Limited, Johnson & Johnson (Thailand) Ltd., Johnson & Johnson AB, Johnson & Johnson AG, Johnson & Johnson Belgium Finance Company, Johnson & Johnson Consumer (Hong Kong) Limited, Johnson & Johnson Consumer (Thailand) Limited, Johnson & Johnson Consumer Holdings France, Johnson & Johnson Consumer Inc., Johnson & Johnson Consumer Services EAME Ltd., Johnson & Johnson European Treasury Company, Johnson & Johnson Finance Corporation, Johnson & Johnson Finance Limited, Johnson & Johnson Financial Services GmbH, Johnson & Johnson Gesellschaft m.b.H., Johnson & Johnson GmbH, Johnson & Johnson Group Holdings GmbH, Johnson & Johnson Health Care Systems Inc., Johnson & Johnson Hellas Commercial and Industrial S.A., Johnson & Johnson Holding GmbH, Johnson & Johnson Inc., Johnson & Johnson Industrial Ltda., Johnson & Johnson Innovation - JJDC, Johnson & Johnson Innovation Limited, Johnson & Johnson International, Johnson & Johnson International Financial Services Company, Johnson & Johnson Japan Inc., Johnson & Johnson K.K., Johnson & Johnson Korea, Johnson & Johnson Korea Selling & Distribution Limited Liability Company, Johnson & Johnson LLC, Johnson & Johnson Limitada, Johnson & Johnson Limited, Johnson & Johnson Luxembourg Finance Company Sarl, Johnson & Johnson Management Limited, Johnson & Johnson Medical, Johnson & Johnson Medical (China) Ltd., Johnson & Johnson Medical (Shanghai) Ltd., Johnson & Johnson Medical (Suzhou) Ltd., Johnson & Johnson Medical B.V., Johnson & Johnson Medical GmbH, Johnson & Johnson Medical Korea Limited, Johnson & Johnson Medical Limited, Johnson & Johnson Medical Mexico, Johnson & Johnson Medical NV, Johnson & Johnson Medical Products GmbH, Johnson & Johnson Medical Pty Ltd, Johnson & Johnson Medical S.A., Johnson & Johnson Medical S.p.A., Johnson & Johnson Medical Taiwan Ltd., Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi, Johnson & Johnson Middle East FZ-LLC, Johnson & Johnson Nordic AB, Johnson & Johnson Pacific Pty. Limited, Johnson & Johnson Panama S.A., Johnson & Johnson Poland Sp. z o.o., Johnson & Johnson Private Limited, Johnson & Johnson Pte. Ltd., Johnson & Johnson Pty. Limited, Johnson & Johnson Romania S.R.L., Johnson & Johnson S.A., Johnson & Johnson S.A. de C.V., Johnson & Johnson S.p.A., Johnson & Johnson SDN. BHD., Johnson & Johnson Sante Beaute France, Johnson & Johnson Services, Johnson & Johnson Sihhi Malzeme Sanayi Ve Ticaret Limited Sirketi, Johnson & Johnson Swiss Finance Company Limited, Johnson & Johnson Taiwan Ltd., Johnson & Johnson Urban Renewal Associates, Johnson & Johnson Vision Care, Johnson & Johnson Vision Care (Ireland), Johnson & Johnson Vision Care (Shanghai) Ltd., Johnson & Johnson de Argentina S.A.C. e. I., Johnson & Johnson de Chile S.A., Johnson & Johnson de Colombia S.A., Johnson & Johnson de Mexico, Johnson & Johnson del Ecuador S.A., Johnson & Johnson del Peru S.A., Johnson & Johnson do Brasil Industria E Comercio de Produtos Para Saude Ltda., Johnson & Johnson for Export & Import LLC, Johnson & Johnson s.r.o., Johnson & Johnson s.r.o. (Slovakia), Latam International Investment Company, Latam Properties Holdings, LifeScan, LifeScan Products, LifeScan Scotland Limited, Lifescan (France), McNeil AB, McNeil Consumer Pharmaceuticals Co., McNeil Healthcare (UK) Limited, McNeil Healthcare LLC, McNeil Nutritionals, McNeil Products Limited, McNeil Sweden AB, Medical Devices & Diagnostics Global Services, Medos International Sarl, Medos Sarl, Mentor B.V., Mentor Holding PP, Mentor Medical Systems B.V., Mentor Texas L.P., Mentor Worldwide LLC, Micrus Endovascular LLC, Middlesex Assurance Company Limited, Momenta Pharmaceuticals, NeoStrata Company Inc., NeuWave Medical, Novira Therapeutics, OBTECH Medical Sarl, OMJ Ireland, OMJ PR Holdings, Omrix Biopharmaceuticals Ltd., Ortho Biologics LLC, Ortho Biotech Holding LLC, Orthotaxy, PMC Holdings G.K., PT. Johnson & Johnson Indonesia, Patriot Pharmaceuticals, Penta Pty. Limited, Pulsar Vascular, Rutan Realty LLC, SYNTHES Medical Immobilien GmbH, Shanghai Johnson & Johnson Pharmaceuticals, Spectrum Vision Limited Liability Company, SterilMed, Synthes, Synthes GmbH, Synthes Holding AG, Synthes Lux Finance S.àr.l., Synthes Luxembourg, Synthes Produktions GmbH, Synthes USA, Synthes USA Products, TARIS Biomedical, The Anspach Effort, Turnbuckle Investment Company, Vania Expansion, Verb Surgical, Vogue International, XO1, Xian-Janssen Pharmaceutical Ltd., and Zarbee's Naturals.

Johnson & Johnson was founded in 1886.

The official website for Johnson & Johnson is www.jnj.com.

Johnson & Johnson is headquartered at ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933.

Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The company can be reached via phone at 732-524-0400.